(Q39560814)

English

Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A.

scientific article published on January 1988

Statements

Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A. (English)
Diamantstein T
Mouzaki A
Osawa H
Volk HD
Hahn HJ
Kirkman RL
Strom TB
Tilney NL
Kupiec-Weglinski JW
1 January 1988
177-184

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit